Chemical Constituents from the Aerial Parts of Aster koraiensis with Protein Glycation and Aldose Reductase Inhibitory Activities
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jun | - |
dc.contributor.author | Lee, Yun Mi | - |
dc.contributor.author | Lee, Byong Won | - |
dc.contributor.author | Kim, Joo-Hwan | - |
dc.contributor.author | Kim, Jin Sook | - |
dc.date.available | 2020-02-29T06:46:31Z | - |
dc.date.created | 2020-02-05 | - |
dc.date.issued | 2012-02 | - |
dc.identifier.issn | 0163-3864 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/16610 | - |
dc.description.abstract | Two new eudesmane-type sesquiterpene glucosides, 9 beta-O-(E-p-hydroxycinnamoyl)-1 beta,6 beta-dihydroxy-trans-eu-desm-3-en-6-O-beta-D-glucopyranoside (1) and 9 alpha-O-(E-p-hydroxycinnamoyl)-1 alpha,6 alpha-11-trihydroxy-trans-eudesm-3-en-6-O-beta-D- glucopyranoside (2), were isolated by the activity-guided fractionation of an EtOAc-soluble fraction from the aerial parts of Aster koraiensis. A new dihydrobenzofuran glucoside, (2R,3S)-6-acetyl-2-[1-O-beta-D-glucopyranosyl)-2-propenyl]-5-hydroxy-3-methoxy-2,3-dihydrobenzofuran (3), was also isolated, in addition to 15 known compounds. The structures of 1-3 were determined by spectroscopic data interpretation. All of the isolates were evaluated for in vitro inhibitory activity against the formation of advanced glycation end-products and rat lens aldose reductase. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.relation.isPartOf | JOURNAL OF NATURAL PRODUCTS | - |
dc.subject | COUNTER-CURRENT CHROMATOGRAPHY | - |
dc.subject | GYMNASTER-KORAIENSIS | - |
dc.subject | PHYTOCHEMICAL CONSTITUENTS | - |
dc.subject | DIABETIC CONDITIONS | - |
dc.subject | EPITHELIAL-CELLS | - |
dc.subject | END-PRODUCTS | - |
dc.subject | IN-VITRO | - |
dc.subject | POLYACETYLENE | - |
dc.subject | ENDPRODUCT | - |
dc.subject | EXPRESSION | - |
dc.title | Chemical Constituents from the Aerial Parts of Aster koraiensis with Protein Glycation and Aldose Reductase Inhibitory Activities | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000300601500023 | - |
dc.identifier.doi | 10.1021/np200646e | - |
dc.identifier.bibliographicCitation | JOURNAL OF NATURAL PRODUCTS, v.75, no.2, pp.267 - 270 | - |
dc.identifier.scopusid | 2-s2.0-84863243326 | - |
dc.citation.endPage | 270 | - |
dc.citation.startPage | 267 | - |
dc.citation.title | JOURNAL OF NATURAL PRODUCTS | - |
dc.citation.volume | 75 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Kim, Joo-Hwan | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | COUNTER-CURRENT CHROMATOGRAPHY | - |
dc.subject.keywordPlus | GYMNASTER-KORAIENSIS | - |
dc.subject.keywordPlus | PHYTOCHEMICAL CONSTITUENTS | - |
dc.subject.keywordPlus | DIABETIC CONDITIONS | - |
dc.subject.keywordPlus | EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | END-PRODUCTS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | POLYACETYLENE | - |
dc.subject.keywordPlus | ENDPRODUCT | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.relation.journalResearchArea | Plant Sciences | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Plant Sciences | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.